Clinical evaluation of meropenem-vaborbactam combination for the treatment of urinary tract infection: evidence to date

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - Taylor & Francis
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - dovepress.com
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

F Herald, RM Burgos - Infection and drug resistance, 2023 - pubmed.ncbi.nlm.nih.gov
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

F Herald, R Burgos - Infection and Drug Resistance, 2023 - europepmc.org
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

[HTML][HTML] Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - ncbi.nlm.nih.gov
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date.

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - go.gale.com
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - search.proquest.com
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …

Clinical Evaluation of Meropenem-Vaborbactam Combination for the Treatment of Urinary Tract Infection: Evidence to Date.

F Herald, RM Burgos - Infection and Drug Resistance, 2023 - europepmc.org
As antimicrobial resistance continues to grow, one of the biggest threats includes the
members of the Enterobacterales order presenting with carbapenem resistance (CRE) …